A

AptaBio Therapeutics Inc
KOSDAQ:293780

Watchlist Manager
AptaBio Therapeutics Inc
KOSDAQ:293780
Watchlist
Price: 9 130 KRW 0.77% Market Closed
Market Cap: 245.4B KRW

AptaBio Therapeutics Inc
Investor Relations

Aptabio Therapeutics, Inc. operates as a pharmaceutical biotechnology company that develops intractable innovative drugs based on original platform technology. The company is headquartered in Yongin, Gyeonggi-Do and currently employs 28 full-time employees. The company went IPO on 2019-06-12. The firm is developing anti-cancer drugs, drugs for inflammatory and fibrotic diseases and diabetic complications drugs, among others.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Dr. Jin Lee Soo
Chief Executive Officer
No Bio Available
Dr. Hwan Moon Sung
President & CSO
No Bio Available

Contacts

Address
GYEONGGI-DO
Yongin
3004, Tower Dong, Heungdeok IT Valley, 13, Heungdeok 1-ro, Giheung-gu
Contacts
+82313653693
www.aptabio.com